The old is new: Lipid therapy and CKD.
On the heels of the 2013 American College of Cardiology/American Heart Association guidelines for lipid therapy, Kidney Disease: Improving Global Outcomes (KDIGO) released updated guidelines for managing hyperlipidemia in patients with chronic kidney disease. This article describes the KDIGO guidelines' focus on individualized cardiovascular risk assessment and treatment.